Christopher M. Murphy - 01 Mar 2025 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Reporting relationship: Chief Financial & Bus. Officer
Issuer ticker: THRD
Reported as of: 01 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2025, 16:01:29 UTC
Prior SEC filing: 17 Jan 2025
Next SEC filing: 14 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Christopher Murphy

Key filing fact

Christopher M. Murphy filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 05 Mar 2025.

Key facts

This page summarizes Christopher M. Murphy's Form 4 filing for Third Harmonic Bio, Inc. (THRD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2025, 16:01.

Change

Previous filing in this sequence was filed on 17 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THRD transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +30,000
Change %
Price: $0.000000
Shares after: 30,000
Date: 01 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

The RSU vests 100% on the one year anniversary of the grant date, subject to continued service through each vesting date.